The DOI matches its Crossref record.
Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Depending on the nature of the drug, methods such as plasmid transfection [38], saturated solution incubation [39], sonication [40], and electroporation [16] can be used to load drugs into EVs.”
From Engineered Extracellular Vesicles Loaded with MiR-100-5p Antagonist Selectively Target the Lesioned Region to Promote Recovery from Brain Damage (2025) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 24
- Bhaumik, 2008, Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells, Oncogene, 10.1038/onc.2008.171 · DOI
- Burgess, 2008, Epigenetic changes in gliomas, Cancer Biol. Ther., 7, 1326, 10.4161/cbt.7.9.6992 · DOI
- Chen, 2011, Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs, J. Transl. Med., 9, 47, 10.1186/1479-5876-9-47 · DOI
- Croce, 2009, Causes and consequences of microRNA dysregulation in cancer, Nat. Rev. Genet., 10, 704, 10.1038/nrg2634 · DOI
- Dillman, 2004, Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma, J. Immunother., 27, 398, 10.1097/00002371-200409000-00009 · DOI
- Geletneky, 2012, Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol, BMC Cancer, 12, 99, 10.1186/1471-2407-12-99 · DOI
- Geraldo, 2012, MicroRNA miR-146b-5p regulates signal transduction of TGF-beta by repressing SMAD4 in thyroid cancer, Oncogene, 31, 1910, 10.1038/onc.2011.381 · DOI
- Guduric-Fuchs, 2012, Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types, BMC Genomics, 13, 357, 10.1186/1471-2164-13-357 · DOI
- Hatanpaa, 2010, Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance, Neoplasia, 12, 675, 10.1593/neo.10688 · DOI
- He, 2011, Reduced expression of SMAD4 in gliomas correlates with progression and survival of patients, J. Exp. Clin. Cancer Res., 30, 70, 10.1186/1756-9966-30-70 · DOI
- Hu, 2012, Exosomal miRNAs: biological properties and therapeutic potential, Front. Genet., 3, 56, 10.3389/fgene.2012.00056 · DOI
- Katakowski, 2010, Functional microRNA is transferred between glioma cells, Cancer Res., 70, 8259, 10.1158/0008-5472.CAN-10-0604 · DOI
- Katakowski, 2010, MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma, Cancer Invest., 28, 1024, 10.3109/07357907.2010.512596 · DOI
- Lal, 2002, Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion, Cancer Res., 62, 3335
- Markert, 2009, Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM, Mol. Ther., 17, 199, 10.1038/mt.2008.228 · DOI
- Mellinghoff, 2011, Signal transduction inhibitors and antiangiogenic therapies for malignant glioma, Glia, 59, 10.1002/glia.21137 · DOI
- Oshiro, 2006, Evaluation of intratumoral administration of tumor necrosis factor-alpha in patients with malignant glioma, Anticancer Res., 26, 4027
- Rasheed, 1992, Loss of heterozygosity for 10q loci in human gliomas, Genes Chromosomes Cancer, 5, 75, 10.1002/gcc.2870050111 · DOI
- Riemenschneider, 2010, Molecular diagnostics of gliomas: state of the art, Acta Neuropathol., 120, 567, 10.1007/s00401-010-0736-4 · DOI
- Shao, 2011, PDGF induced microRNA alterations in cancer cells, Nucl. Acids Res., 39, 4035, 10.1093/nar/gkq1305 · DOI
- Silber, 2009, MicroRNAs in gliomas: small regulators of a big problem, Neuromol. Med., 11, 208, 10.1007/s12017-009-8087-9 · DOI
- Turner, 2010, The many roles of microRNAs in brain tumor biology, Neurosurg. Focus, 28, E3, 10.3171/2009.10.FOCUS09207 · DOI
- Xin, 2012, Exosome mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth, Stem Cells, 10.1002/stem.1129 · DOI
- Zheng, 2012, Studying a complex tumor: potential and pitfalls, Cancer J., 18, 107, 10.1097/PPO.0b013e3182431c57 · DOI
Cited by
Sorted by citations
The biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
Concise review: MSC-derived exosomes for cell-free therapy
Phinney, D. G., & Pittenger, M. F. (2017) · Stem Cells · doi:10.1002/stem.2575 · Cited by 1,834
Zhang, Y., Chopp, M., Meng, Y., Katakowski, M., Xin, H., Mahmood, A., & Xiong, Y. (2015) · Journal of neurosurgery · doi:10.3171/2014.11.jns14770 · Cited by 737
Self-citationTherapeutically harnessing extracellular vesicles
Cheng, L., & Hill, A. F. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00410-w · Cited by 737
Johnsen, K. B., Gudbergsson, J. M., Skov, M. N., Pilgaard, L., Moos, T., & Duroux, M. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.04.005 · Cited by 704
Exosome engineering: Current progress in cargo loading and targeted delivery
Fu, S., Wang, Y., Xia, X., & Zheng, J. C. (2020) · NanoImpact · doi:10.1016/j.impact.2020.100261 · Cited by 444
Engineered Extracellular Vesicles for Cancer Therapy
Zhang, X., Zhang, H., Gu, J., Zhang, J., Shi, H., Qian, H., Wang, D., Xu, W., Pan, J., & Santos, H. A. (2021) · Advanced Materials · doi:10.1002/adma.202005709 · Cited by 428
Chen, H.-X., Liang, F.-C., Gu, P., Xu, B.-L., Xu, H.-J., Wang, W.-T., Hou, J.-Y., Xie, D.-X., Chai, X.-Q., & An, S.-J. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2473-5 · Cited by 319
Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
Zhang, Y., Liu, Q., Zhang, X., Huang, H., Tang, S., Chai, Y., Xu, Z., Li, M., Chen, X., Liu, J., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01472-z · Cited by 306
Exosome-Based Drug Delivery: Translation from Bench to Clinic
Koh, H. B., Kim, H. J., Kang, S.-W., & Yoo, T.-H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082042 · Cited by 259
Current Knowledge on Exosome Biogenesis, Cargo-Sorting Mechanism and Therapeutic Implications
Xie, S., Zhang, Q., & Jiang, L. (2022) · Membranes · doi:10.3390/membranes12050498 · Cited by 262
O’Brien, K. P., Khan, S., Gilligan, K. E., Zafar, H., Lalor, P., Glynn, C., O’Flatharta, C., Ingoldsby, H., Dockery, P., De Bhulbh, A., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0116-9 · Cited by 215
Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications
Amiri, A., Bagherifar, R., Ansari Dezfouli, E., Kiaie, S. H., Jafari, R., & Ramezani, R. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03325-7 · Cited by 186
Psaraki, A., Ntari, L., Karakostas, C., Korrou‐Karava, D., & Roubelakis, M. G. (2022) · Hepatology · doi:10.1002/hep.32129 · Cited by 145
Exosomes in cancer: Use them or target them?
Bastos, N., Ruivo, C. F., da Silva, S., & Melo, S. A. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.08.009 · Cited by 140
Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy
Wang, X., Wang, L., Lin, H., Zhu, Y., Huang, D., Lai, M., Xi, X., Huang, J., Zhang, W., & Zhong, T. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1303335 · Cited by 112
Extracellular vesicles in cancer nanomedicine
Tarasov, V. V., Svistunov, A. A., Chubarev, V. N., Dostdar, S. A., Sokolov, A. V., Brzecka, A., Sukocheva, O., Neganova, M. E., Klochkov, S. G., Somasundaram, S. G., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.017 · Cited by 97
Exosome-based small RNA delivery: Progress and prospects
Lu, M., Xing, H., Xun, Z., Yang, T., Ding, P., Cai, C., Wang, D., & Zhao, X. (2018) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2017.07.008 · Cited by 97
Exosomes in neurologic and psychiatric disorders
Tsilioni, I., Panagiotidou, S., & Theoharides, T. C. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.05.005 · Cited by 93
Emerging prospects of extracellular vesicles for brain disease theranostics
Wang, R., Wang, X., Zhang, Y., Zhao, H., Cui, J., Li, J., & Di, L. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.024 · Cited by 48
Yu, Y., Abudula, M., Li, C., Chen, Z., Zhang, Y., & Chen, Y. (2019) · Respiratory Research · doi:10.1186/s12931-019-1202-z · Cited by 33
Recent Progress in Extracellular Vesicle-Based Carriers for Targeted Drug Delivery in Cancer Therapy
Tang, Y., Liu, X., Sun, M., Xiong, S., Xiao, N., Li, J., He, X., & Xie, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071902 · Cited by 24
Extracellular Vesicles and Their Interplay with Biological Membranes
Yeo Xian Ping, J., Raj Neupane, Y., & Pastorin, G. (2022) · Physiology · doi:10.5772/intechopen.101297 · Cited by 9
Cheng, Y., Gai, C., Zhao, Y., Li, T., Song, Y., Luo, Q., Xin, D., Jiang, Z., Chen, W., Liu, D., et al. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01376-6 · Cited by 5
Metadata
- Authors
- Katakowski, M., Buller, B., Zheng, X., Lu, Y., Rogers, T., Osobamiro, O., Shu, W., Jiang, F., & Chopp, M.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 335
- Issue
- 1
- Pages
- 201-204
- ISSN
- 0304-3835
- PMC
- PMC3665755
- Cited by
- 681
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
